Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund

A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.

A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.

  1. Home
  2. Subjects
  3. meta analysis
meta analysis
Tamiflu Reviewed Again
Tamiflu Reviewed Again
Kerry Grens | Jan 30, 2015
The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 
EMA Gearing Up for Transparency
EMA Gearing Up for Transparency
Kerry Grens | Jun 16, 2014
The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  
Updated Review: Tamiflu Is a Bust
Updated Review: Tamiflu Is a Bust
Kerry Grens | Apr 10, 2014
After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.
Resveratrol May Not Extend Life
Hayley Dunning | Jun 20, 2012
A new meta-analysis finds that resveratrol, currently marketed as a life-extending health supplement, may have a negligible effect on lifespan in humans.
FDA Disputes Data Under-Reporting
Sabrina Richards | May 2, 2012
The FDA and NIH dispute reports that clinical trial data is being under-reported.
With All Due Consideration
Mary Beth Aberlin | May 1, 2012
Scientists and their many hats
Tall Women Beware
Edyta Zielinska | Apr 5, 2012
Extra inches may mean a higher chance of getting ovarian cancer.
Bird Flu Prevalence Underestimated
Hannah Waters | Feb 23, 2012
Pooled data from H5N1 bird flu studies suggests that the World Health Organization may be underestimating infection and overestimating fatality.